ATE540968T1 - Alpha-fetoproteinpeptide und deren verwendungen - Google Patents

Alpha-fetoproteinpeptide und deren verwendungen

Info

Publication number
ATE540968T1
ATE540968T1 AT02791271T AT02791271T ATE540968T1 AT E540968 T1 ATE540968 T1 AT E540968T1 AT 02791271 T AT02791271 T AT 02791271T AT 02791271 T AT02791271 T AT 02791271T AT E540968 T1 ATE540968 T1 AT E540968T1
Authority
AT
Austria
Prior art keywords
modulators
amino acid
acid structures
methods
therapy
Prior art date
Application number
AT02791271T
Other languages
English (en)
Inventor
Thomas Andersen
James Bennett
Herbert Jacobson
Fassil Mesfin
Original Assignee
Albany Medical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albany Medical College filed Critical Albany Medical College
Application granted granted Critical
Publication of ATE540968T1 publication Critical patent/ATE540968T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT02791271T 2001-11-20 2002-11-20 Alpha-fetoproteinpeptide und deren verwendungen ATE540968T1 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US33184101P 2001-11-20 2001-11-20
US34092601P 2001-12-07 2001-12-07
US39737302P 2002-07-19 2002-07-19
US39701202P 2002-07-19 2002-07-19
US40910902P 2002-09-09 2002-09-09
PCT/US2002/037070 WO2003044040A2 (en) 2001-11-20 2002-11-20 Alpha-fetoprotein peptides and uses thereof

Publications (1)

Publication Number Publication Date
ATE540968T1 true ATE540968T1 (de) 2012-01-15

Family

ID=27541106

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02791271T ATE540968T1 (de) 2001-11-20 2002-11-20 Alpha-fetoproteinpeptide und deren verwendungen

Country Status (6)

Country Link
US (1) US7122522B2 (de)
EP (1) EP1448593B1 (de)
AT (1) ATE540968T1 (de)
AU (1) AU2002365974A1 (de)
CA (1) CA2467756A1 (de)
WO (1) WO2003044040A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7943577B2 (en) * 2001-11-20 2011-05-17 Albany Medical College Alpha-fetoprotein peptides and uses thereof
CA2537273A1 (en) * 2003-09-05 2005-03-17 Gtc Biotherapeutics, Inc. Method for the production of fusion proteins in transgenic mammal milk
SE0401302D0 (sv) * 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Inhibition of erk-phosphorylation
US7964701B2 (en) 2006-02-24 2011-06-21 Albany Medical College Alpha-fetoprotein peptides
US7598342B2 (en) * 2006-02-24 2009-10-06 Albany Medical College Alpha-fetoprotein peptides and uses thereof
WO2011088462A2 (en) 2010-01-18 2011-07-21 Albany Medical College Alpha-fetoprotein 'ring and tail' peptides
CN102628869B (zh) * 2012-04-19 2014-04-02 上海蓝怡科技有限公司 提高甲胎蛋白抗体冻干稳定性的制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674842A (en) * 1994-10-26 1997-10-07 Health Research, Incorporated Growth inhibitory peptide
BR9808863A (pt) 1997-04-14 2001-09-18 Univ California Composições antiestrogênicas peptìdicas e métodos para tratar câncer de mama
WO2003007978A1 (en) * 2001-06-02 2003-01-30 Clf Medical Technology Acceleration Program, Inc. Alpha-fetoprotein peptides and uses thereof

Also Published As

Publication number Publication date
AU2002365974A1 (en) 2003-06-10
EP1448593A2 (de) 2004-08-25
WO2003044040A9 (en) 2005-01-06
EP1448593B1 (de) 2012-01-11
AU2002365974A8 (en) 2003-06-10
EP1448593A4 (de) 2006-08-30
US7122522B2 (en) 2006-10-17
WO2003044040A3 (en) 2004-01-22
US20060199769A1 (en) 2006-09-07
WO2003044040A2 (en) 2003-05-30
CA2467756A1 (en) 2003-05-30

Similar Documents

Publication Publication Date Title
ES2389670T3 (es) Uso del PIG para el tratamiento de trastornos asociados a la transmisión sináptica desfuncional
ATE531729T1 (de) Kdr-peptide und diese enthaltende impfstoffe
IL161591A (en) Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
IL197686A0 (en) Pharmaceutical compositions containing alpha-4 integrin antagonists and uses thereof in the treatment of multiple myeloma and diseases associated therewith
CA2596597A1 (en) Method for stimulation collagen synthesis and/or kgf expression
BR0110049A (pt) Agonista de cxcr4, uso de um agonista de cxcr4, e composição farmacêutica
BRPI0406796A (pt) Métodos para tratar hipertrofia prostática benigna, para reduzir um sintoma associado com a mesma, para reduzir o tamanho da próstata em um indivìduo humano e para profilaxia de bhp, composição farmacêutica oral de dose unitária, e, uso de lonidamina ou um análogo de lonidamina
ATE152628T1 (de) Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
CA2449284A1 (en) Alpha-fetoprotein peptides and uses thereof
ATE540968T1 (de) Alpha-fetoproteinpeptide und deren verwendungen
BR9916323A (pt) Inibidores da integrina alfavbeta6
CN102482323A (zh) 新型肽及其应用
ATE230609T1 (de) Verfahren zur behandlung von entzündungen und zusammensetzungen dafür
MXPA00010254A (es) Tratamiento de disfuncion sexual en ciertos grupos de pacientes.
BR0315609A (pt) Método de tratar, prevenir, modificar ou controlar dor e composição farmacêutica
ES2842523T3 (es) Métodos y composiciones para el tratamiento de la artritis
GB9930768D0 (en) Composition
YU60199A (sh) Nove soli bpc peptida sa organo-zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena u terapiji
WO2001087039A3 (en) Treatment of neoplasia / transformation using pituitary tumor transforming gene 2
EP1282641A4 (de) MENSCHLICHES, GEBäRMUTTERKREBS-SPEZIFISCHES SUPPRESSORPROTEIN, FüR DAS PROTEIN KODIERES POLYNUKLEOTID, MIT DEM POLYNUKLEOTID TRANSFORMIERTE ZELLE UND VERFAHREN ZUR UNTERDRüCKUNG DER PROLIFERATION VON KREBSZELLEN UNTER VERWENDUNG DES EXPRESSIONSVEKTORS
ATE420890T1 (de) Isoleucyl-valyl-threonyl-asparaginyl-threonyl- threonin (ivtntt) enthaltende biologisch wirksame peptide
CA2465245A1 (en) Biologically active peptides and their use for repairing injured nerves
SE9302414D0 (sv) Peptid med oxytocinantagonist-aktivitet
RU2780890C2 (ru) Способ лечения доброкачественной гиперплазии предстательной железы с помощью антибиотиков
Zucker et al. Asperlicin: a unique nonpeptide cholecystokinin antagonist